Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Hemachandra Reddy
Texas Tech University Health Scis Center, Department: None
Should you be removed from our database? Contact us at [email protected]. Read more below.
abSynap Tex, LLC
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
The TTUHSC Conflict of Interest in Research Committee (COIRC) has determined that Dr. Reddy has a conflict of interest as defined by HSC OP 73.09, Conflict of Interest in Research, as a consequence of his financial interest in abSynapTex, LLC., Lubbock, TX, a drug development start-up company that has a licensing agreement with Texas Tech University System (TTUS), and in which Dr. Reddy is a founding Principal, stockholder, Chief Scientific Officer, and consultant. The conflict derives from the potential for Dr. Reddy to benefit financially from company and IP ownership interests that could be influenced by results of ongoing research in his laboratory.
Mitochondrial Fragmentation and Neurodegeneration in Huntington's Disease
Mitochondrial dysfunction and oxidative damage are involved in Huntington's disease (HD) pathogenesis. The objectives of the proposed research are to determine whether a partial reduction of the mitochondrial fission protein, Drp1 protects against excessive mutant huntingtin-induced mitochondrial fragmentation, mitochondrial dysfunction, and synaptic toxicities; and to determine whether the mitochondrial division inhibitor, Mdivi 1 protects against mutant huntingtin-induced mitochondrial toxicity and synaptic alterations, and enhances neuronal function and survival in HD-affected neurons.
Filed on November 07, 2017.
Tell us what you know about Hemachandra Reddy's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Hemachandra Reddy filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Hemachandra Reddy | Texas Tech University Health Scis Center | Conflict of Interest | abSynapTex, LLC | Value cannot be readily determined |
| Hemachandra Reddy | Texas Tech University Health Scis Center | Conflict of Interest | abSynapTex, LLC | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.